From: Stratification of cancer and diabetes based on circulating levels of formate and glucose
Study/condition | Country | Sample | Assay | Cases | Controls | Formate | Fold change | Significance | Ref |
---|---|---|---|---|---|---|---|---|---|
Death vs asymptomatic/methanol poisoning | Czech Republic | Serum | Enzymatic | 6 | 15 | ↑ | 8 | 4.0E−3 | [26] |
Amyotrophic lateral sclerosis | India | Serum | NMR | 30 | 25 | ↑ | NR | < 0.001 | [24] |
Parkinson’s disease vs healthy | India | Serum | NMR | 17 | 22 | ↑ | 3 | < 0.001 | [25] |
Crohn’s disease | Canada | Serum | NMR | 20 | 40 | ↑ | NR | < 0.05 | [23] |
Ulcerative colitis | Canada | Serum | NMR | 20 | 40 | ↑ | NR | < 0.05 | [23] |
Non-Hodgkin’s lymphoma | Poland | Serum | NMR | 26 | 31 | ↑ | 1.7 | < 0.05 | [18] |
Chronic lymphocytic leukaemia | Poland | Serum | NMR | 21 | 31 | ↑ | 1.5 | < 0.05 | [18] |
Acute myeloid leukaemia | Poland | Serum | NMR | 38 | 31 | ↑ | 2.0 | < 0.05 | [18] |
Colorectal cancer vs healthy | China | Othera | NMR | 127 | 43 | ↑ | NR | 1.0E−3 | [17] |
Colorectal cancer vs healthy | Denmark | Serum | NMR | 153 | 139 | ↑ | 1.2 | 1.5E−5 | [13] |
Colorectal cancer vs healthy | China | Serum | NMR | 28 | 55 | – | NR | > 0.05 | [27] |
Chronic pancreatitis vs healthy | China | Plasma | NMR | 20 | 20 | ↑ | NR | < 0.05 | [28] |
Pancreatic cancer vs healthy | China | Plasma | NMR | 19 | 20 | – | NR | > 0.05 | [28] |
Hepatocellular carcinoma | European | Serum | NMR | 114 | 222 | – | NR | > 0.05 | [29] |
Hepatocellular carcinoma | China | Serum | NMR | 24 | 60 | – | 0.25 | > 0.05 | [30] |
Hepatocellular carcinoma | China | Serum | NMR | 43 | 18 | ↓ | 0.07 | < 0.05 | [16] |
Liver cirrhosis | China | Serum | NMR | 42 | 18 | ↓ | 0.36 | < 0.05 | [16] |
Hepatocellular carcinoma vs liver cirrhosis | China | Serum | NMR | 43 | 42 | ↓ | 0.20 | < 0.001 | [16] |
Lung cancer vs healthy | China | Serum | NMR | 39 | 43 | – | 0.87 | > 0.05 | [31] |
Lung cancer vs healthy | Portugal | Plasma | NMR | 85 | 78 | ↓ | 0.7 | 3.6E−5 | [14] |
Lung cancer vs healthy | China | Serum | NMR | 27 | 24 | ↓ | 0.5 | NA | [15] |
Progressive disease vs response/breast cancer | Singapore | Serum | NMR | 7 | 22 | ↓ | NR | < 0.05 | [32] |
Obesity vs Non/colorectal cancer | Denmark | Serum | NMR | 78 | 21 | ↓ | NR | 7.8E−3 | [13] |
Type 2 diabetes vs healthy | Otherb | Serum | NMR | 8 | 8 | ↓ | 0.3 | < 0.05 | [12] |